Published in Virus Weekly, June 24th, 1996
In addition, measurements of plasma RNA HIV concentrations following treatment "... suggest a favorable effect of therapy on virus load," according to a multicenter team of researchers (Pediatrics 1996;97:886-890). Dr. Mark W. Kline, Baylor College of Medicine, Houston, Texas, and colleagues reported the results of a preliminary pediatric trial of combination treatment with stavudine and didanosine.
"Stavudine is not [U.S. Food and Drug Administration] [FDA] approved for use in children, but a pediatric Phase I and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
Source: Virus Weekly (1996-06-24)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.